Publikationer
Emborg C, Kothari SF, Finnerup NB, Vase L. Minimizing placebo responses in clinical trials. I Benedetti F, Shaibani A, red., Placebo Effects in Neurology. Bind 213. Elsevier. 2025. s. 265-275. (Handbook of Clinical Neurology, Bind 213). doi: 10.1016/B978-0-443-29884-4.00018-2
Galosi E, Litewczuk D, De Stefano G, Di Pietro G, Di Stefano G, Esposito N et al. Diagnostic accuracy of quantitative sensory testing for detecting small fiber impairment in polyneuropathy and diagnosing small fiber neuropathy. Pain. 2025. Epub 2025. doi: 10.1097/j.pain.0000000000003685
Gehr NL, Timm S, Bennedsgaard K, Grosen K, Jakobsen E, Jensen AB et al. Chronic chemotherapy-induced peripheral neuropathy and pain following paclitaxel versus docetaxel in breast cancer survivors: A cross-sectional study. The Breast. 2025 apr.;80:104424. doi: 10.1016/j.breast.2025.104424
Gehr NL, Mortensen C, Stage TB, Pedersen MRV, Rafaelsen SR, Madsen JS et al. Neurofilament light chain as a marker for neuronal damage: integrating in vitro studies and clinical findings in patients with oxaliplatin-induced neuropathy. Cancer Chemotherapy and Pharmacology. 2025 dec.;95(1):53. doi: 10.1007/s00280-025-04773-w
Gormsen L, Fink P, Butler SH, Henningsen P, Loeser JD, Rief W et al. Can the pain field learn from the functional somatic disorder field? Pain. 2025 dec.;166(12):2689-2692. Epub 2025 sep. 21. doi: 10.1097/j.pain.0000000000003733
Hansen JS, Rasmussen PV, Finnerup NB, Svandsen KB. Patient's and researcher's perspectives on patient involvement in research in multiple sclerosis. Danish Medical Journal. 2025 nov. 19;72(12):A04250351. doi: 10.61409/A04250351
Hjelholt AJ, Bach FW, Kasch H, Støvring H, Jensen TS, Jørgensen JOL. Cabergoline as a preventive migraine treatment: A randomized clinical pilot trial. PLoS One. 2025 apr.;20(4 April):e0320937. doi: 10.1371/journal.pone.0320937
Jia A, Price TR, Rosner J, Broderick C, Cragg JJ. Journal Club: Cancer Risk Among Patients With Multiple Sclerosis: A 10-Year Nationwide Retrospective Cohort Study. Neurology. 2025 jun. 5;105(1). doi: 10.1212/WNL.0000000000213663
Kapel JS, Stokholm R, Elmengaard B, Nochi Z, Olsen RKJ, Foldager CB. Individualized Algorithm-Based Intermittent Hypoxia Improves Quality of Life in Patients Suffering from Long-Term Sequelae After COVID-19 Infection. Journal of Clinical Medicine. 2025 mar.;14(5):1590. doi: 10.3390/jcm14051590
Kaur G, Ali SO, Santos A, Okdahl T, Wegeberg AM, Ahluwalia TS et al. Current advances in diabetic neuropathy: Proteins as therapeutic targets. iScience. 2025 okt. 17;28(10):113466. doi: 10.1016/j.isci.2025.113466
Krogsbaek M, Larsen NY, Yarmahmoudi F, Søndergaard J, Landau AM, Sanchez C et al. Chronic olanzapine treatment leads to increased opioid receptor expression and changes in feeding regulating neurons in the female rat hypothalamus. Psychoneuroendocrinology. 2025 jan.;171:107225. doi: 10.1016/j.psyneuen.2024.107225
Määttä LL, Andersen ST, Parkner T, Hviid CVB, Witte DR, John J et al. Serum Neurofilament Light Chain and Structural and Functional Nerve Fiber Loss in Painful and Painless Diabetic Polyneuropathy. Diabetes Research and Clinical Practice. 2025 maj;223:112098. doi: 10.1016/j.diabres.2025.112098
Niedernhuber M, Fardo F, Allen M, Bekinschtein T. Supramodal and modality-specific neural information supports multi-feature prediction errors across cortical levels. Imaging Neuroscience. 2025 sep. 15;3:IMAG.a.149. doi: 10.1162/IMAG.a.149
Nochi Z, Pia H, Bloms-Funke P, Boesl I, Caspani O, Chapman SC et al. Effects of Lacosamide, Pregabalin, and Tapentadol on Peripheral Nerve Excitability: A randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects. Anesthesiology. 2025 nov.;143(5):1279-1295. Epub 2025. doi: 10.1097/ALN.0000000000005694
Omoniyi AA, Hammer RE, Josefsen S, Richner M, Lezmi S, Vægter CB et al. The Activities of Recombinant Botulinum Toxin A on Spared Nerve Injury-Induced Neuropathic Pain in a Diabetic Mice Model. Toxins. 2025 nov. 3;17(11):545. doi: 10.3390/toxins17110545
Papadomanolakis-Pakis N, Haroutounian S, Sørensen JK, Runge C, Brix LD, Christiansen CF et al. Development and internal validation of a clinical risk tool to predict chronic postsurgical pain in adults: a prospective multicentre cohort study. Pain. 2025 mar. 1;166(3):667-679. 3405. Epub 2024 sep. 18. doi: 10.1097/j.pain.0000000000003405
Rasmussen VF, Thrysøe M, Karlsson P, Nyengaard JR, Kristensen K, Vestergaard ET. Impact of Neuropathy on Well-Being and Health-Related Quality of Life in Adolescents With Type 1 Diabetes. Journal of Diabetes Research. 2025;2025(1):6620727. Epub 2025 apr.. doi: 10.1155/jdr/6620727
Savelieff MG, Elafros MA, Viswanathan V, Jensen TS, Bennett DL, Feldman EL. The global and regional burden of diabetic peripheral neuropathy. Nature Reviews Neurology. 2025 jan.;21(1):17-31. e209652. doi: 10.1038/s41582-024-01041-y
Schaldemose EL, Brask-Thomsen PK, Itani M, Fardo F, Karlsson P, Kristensen AG et al. A longitudinal study of paradoxical heat sensation in 420 individuals. Pain. 2025. Epub 2025. doi: 10.1097/j.pain.0000000000003652
Scheuren PS, Hupp M, Pfender N, Seif M, Zipser CM, Wanivenhaus F et al. Contact heat evoked potentials reveal distinct patterns of spinal cord impairment in degenerative cervical myelopathy beyond MRI lesions. European Journal of Neurology. 2025 jan.;32(1):e70001. doi: 10.1111/ene.70001
Soliman N, Moisset X, Attal N, Finnerup NB, Haroutounian S. Caution on the use of α2δ-ligands in neuropathic pain – Authors' reply. The Lancet Neurology. 2025 dec.;24(12):993-994. doi: 10.1016/S1474-4422(25)00384-9
Soliman N, Moisset X, Ferraro MC, de Andrade DC, Baron R, Belton J et al. Pharmacotherapy and non-invasive neuromodulation for neuropathic pain: a systematic review and meta-analysis. The Lancet Neurology. 2025 maj;24(5):413-428. doi: 10.1016/S1474-4422(25)00068-7
Theologidis V, Ferreira SA, Jensen NM, Gomes Moreira D, Ahlgreen OA, Hansen MW et al. Bradykinesia and postural instability in a model of prodromal synucleinopathy with α-synuclein aggregation initiated in the gigantocellular nuclei. Acta Neuropathologica Communications. 2025 feb. 17;13(1):32. 32. doi: 10.1186/s40478-025-01948-7
Thiyagarajah A, Terkelsen AJ, Birklein F, Finnerup NB, Gylfadottir SS. The Effect of Fremanezumab on Pain in Patients with Complex Regional Pain Syndrome: Study Protocol of a Randomized, Double-Blind, Proof-of-Concept, Placebo-Controlled Trial. Brain sciences. 2025 maj;15(5):468. doi: 10.3390/brainsci15050468
Thrysøe M, Parkner T, Tankisi H, Nyengaard JR, Vestergaard ET, Kristensen K et al. Biochemical use of neurofilament light polypeptide and vitamin B12 in relation to diabetic polyneuropathy in Danish adolescents with type 1 diabetes: a cross-sectional study. BMJ Open. 2025 mar. 3;15(3):e085749. doi: 10.1136/bmjopen-2024-085749
Søg efter en publikation
